It has been shown that SLC22A3 is involved in the uptake of cisplatin, and in head and neck or colorectal cancer upregulated SLC22A3 expression improved cisplatin uptake and survival of the patients [20,46]. The gene discussed is SLC22A3; the disease is colorectal cancer.